Physician Resources

CDC now offering CME course on HPV vaccination


 

The Centers for Disease Control and Prevention is now offering a CME course to educate clinicians about the importance of human papillomavirus (HPV) vaccination in protecting adolescents from certain types of cancer and to provide them with the skills and resources to make effective HPV vaccine recommendations.

The course is a Web-on-demand video that will teach clinicians how to be successful in making HPV vaccination recommendations, how to communicate HPV vaccination information to parents and patients, and how to properly answer parents’ questions. Currently, the CDC recommends the HPV vaccine for adolescents at 11- to 12-years-of-age. The CDC hopes this will reduce missed opportunities to protect patients against HPV.

young girl receiving vaccine in doctor office Dzurag/iStock/Getty Images

Speakers in the video include Alix Casler, MD, of the Orlando Family Physician Association; Linda Fu, MD, MS, of Children’s National Health System in Washington; Todd Wolynn, MD, president and CEO of Kids Plus Pediatrics, Pittsburgh; and Wendy Sue Swanson, MD, MBE, a pediatrician who is chief of digital innovation at Seattle Children’s Hospital.

The course was initiated in Jan. 16, 2018, and will continue until Jan. 16, 2020. Anyone who provides immunization to patients can participate.

The course is called “Routinely Recommending Cancer Prevention: HPV Vaccination at 11 and 12 as a Standard of Care.” Read more about the course on and download it from the CDC’s website.

Recommended Reading

Make adult immunization a profit center
MDedge Family Medicine
Impact of varicella vaccination on herpes zoster is not what was expected
MDedge Family Medicine
Additional training may be warranted for clinicians administering DTaP
MDedge Family Medicine
ACIP votes to recommend new strains for the 2018-2019 flu vaccine
MDedge Family Medicine
Parents say cancer prevention is the best reason to give HPV vaccine
MDedge Family Medicine
Pediatric asthma patients should be considered priority for flu vaccine
MDedge Family Medicine
Norovirus vaccine appears promising in children
MDedge Family Medicine
Anthrax vaccine recommendations updated in the event of a wide-area release
MDedge Family Medicine
Primary efficacy not met by new M. tuberculosis vaccine strategies
MDedge Family Medicine
Immunogenicity of two-dose Gardasil 9 persists at 36 months
MDedge Family Medicine